Comparison

VU0359595 European Partner

Manufacturer TargetMol
Category
Type Inhibitor
Specific against other
Amount 10mg
Item no. TMO-T21777-10mg
CASRN 1246303-14-9
eClass 6.1 30220300
eClass 9.0 32160605
Available
Short Description
VU0359595 is a potent and selective pharmacological phospholipase D1 (PLD1) inhibitor with an IC50 of 3.7 nM. VU0359595 is >1700-fold selective for PLD1 over PLD2 (IC50 of 6.4 μM). VU0359595 can be used for the research of cancer, diabetes, neurodegenerative and inflammatory diseases.
Shipping
cool pack
Storage
-20°
Target names or alias
CID-53361951 , VU0359595-1 , ML-270
Molecular Weight
497, 43
Pathway
Metabolism
Target
Phospholipase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close